TransMedics Group, Inc. (TMDX) — Stock Score Summary

TransMedics Group, Inc. (TMDX) has a MoatMap StockRank of 37/100 based on Quality (71/100), Value (40/100), and Momentum (13/100) factor scores. The current signal is HOLD. TransMedics is a phenomenal growth story (Q: 71) revolutionizing organ transplantation with its Organ Care System (OCS). It exhibits strong Peter Lynch characteristics with visible, surging clinical demand. However, it does not directly align with our core 18-month macro themes, and its high valuation requires a cautious approach despite its immense quality.

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.

Key Financial Metrics

Price$74.29
Market Cap$2.3B
P/E (TTM)16.33
P/E (Forward)20.09
Price/Book5.17
Return on Equity45.2%
Return on Invested Capital12.4%
Debt/Equity174.78
Gross Margin59.1%
Operating Margin7.6%
Revenue Growth21.2%
Free Cash Flow$109M

TransMedics Group, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is TransMedics Group, Inc.’s (TMDX) StockRank?
MoatMap’s StockRank for TransMedics Group, Inc. (TMDX) is 37/100, with a Hold signal. It is a composite of Quality (71), Value (40), and Momentum (13) factor ranks across MoatMap’s 19,000+ stock universe.
Does TransMedics Group, Inc. have an economic moat?
TransMedics Group, Inc. (TMDX) has a Quality factor score of 71/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is TransMedics Group, Inc. a buy, hold, or sell?
MoatMap’s current signal for TransMedics Group, Inc. (TMDX) is Hold, based on a StockRank of 37/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is TransMedics Group, Inc. in?
TransMedics Group, Inc. (TMDX) operates in the Healthcare sector, specifically the Medical Devices industry (United States).
Browse all ranked stocksTMDX deep dive reportAI ChampionsHow we score stocksSense-check another stock